No Detail Found!

Interferon Lambda-3 rs12979860 Variants and Response to Pegylated Interferon in Chronic Hepatitis-C Genotype-3.

Author(s)
Zaigham Abbas Department of Medicine, The Aga Khan University Hospital, Karachi, Pakistan
Javed Yakoob Department of Medicine, The Aga Khan University Hospital, Karachi, Pakistan
Muhammad A Umer Department of Medicine, The Aga Khan University Hospital, Karachi, Pakistan
AliA Azeem Department of Medicine, The Aga Khan University Hospital, Karachi, Pakistan
SaeedS Hamid Department of Medicine, The Aga Khan University Hospital, Karachi, Pakistan
Wasim Jafri Department of Medicine, The Aga Khan University Hospital, Karachi, Pakistan
Abstract
Objective: To assess the role of single nucleotide polymorphisms (SNPs) near the interferon lambda-3 (IFN?3) (formal IL-28B) gene rs12979860 in predicting sustained virologic response (SVR) in hepatitis-C virus genotype-3 (HCV-3). Study Design: Descriptive, analytical study. Place and Duration of Study: Department of Medicine, The Aga Khan University Hospital, Karachi, from July 2012 to June 2014. Methodology: Patients with HCV-3 were classified as sustained virologic response (SVR), relapsers and non-responders. SNP rs12979860 was determined by PCR-RFLP protocol. Differences between categorical variables were assessed by chi-square or Fisher's exact test, while those between continuous variables were evaluated using the Mann-Whitney U-test. Binary logistic regression analysis by forward conditional method was performed by using significant variables with p-values less than 0.05 as the criteria for model inclusion. Results: Out of 115 patients, rs12979860 genotype-CC, CT, TT was found in 37 (32.2%), 70 (60.9%), and 8 (7%) patients. 72 patients were male with median age of 45 years. Cirrhosis was present in 32 patients. Patients with response failures (no response and relapse, n=36 and 29, respectively) had higher baseline gamma glutamyl transferase (GGT) level (p < 0.001), higher alanine aminotransferase (p=0.027) and cirrhosis (p=0.001) than patients with SVR. Genotype-CC was present in 16/65 in response failures compared to 21/50 who achieved SVR (p=0.048). Rapid virologic response (RVR) (p < 0.001), low GGT (p=0.001) and absence of cirrhosis (p=0.039) were the independent predictive factors for SVR. In patients who could not achieve RVR and in patients with cirrhosis, SVR was seen more in with genotype-CC (p=0.007 and 0.038). Conclusion: In patients infected with HCV-3, IFN?3 rs12979860, SNP has less impact on SVR.
Publication Details
Page(s) 481-485
DOI DOI not available
Published Journal: Journal of College of Physicians and Surgeons--Pakistan : JCPSP, Volume: 26, Issue: 6, Year: 2016

Request the full text from PASTIC

References
GeD,FellayJ,ThompsonAJ,SimonJS,ShiannaKV,UrbanTJ, 2009.Genetic variation in IL-28B predicts hepatitis-C treatmentinduced viral clearance,Nature 461 399 -401
ThompsonAJ,MuirAJ,SulkowskiMS,GeD,FellayJ,ShiannaKV, 2010.Interleukin-28B polymorphism improves viral kinetics and is the strongest pre-treatment predictor of sustained virologic response in hepatitis-C virus-1 patients,Gastroenterology 139 120 -9
McHutchisonJG,LawitzEJ,MuirAJ,GallerGW,McConeJ, 2009.Peginterferon alfa-2b or alfa-2a with ribavirin for treatment of hepatitis-C infection,N Engl J Med 36 580 -93
ThomasDL,ThioCL,MartinMP,QiY,GeD,O'HuiginC, 2009.Genetic variation in IL-28B and spontaneous clearance of hepatitis-C virus,Nature 461 798 -801
ButiM,EstebanR, 2015.Hepatitis-C virus genotype-3: a genotype that is not 'easy-to-treat',Expert Rev Gastroenterol Hepatol 9 375 -85
FabrisC,FalletiE,CussighA,BitettoD,FontaniniE, 2011.-28B rs12979860 C/T allele distribution in patients with liver cirrhosis: role in the course of chronic viral hepatitis and the development of HCC,J Hepatol 54 716 -22
LanghansB,KupferB,BraunschweigerI,ArndtS,SchulteW,NischalkeHD, 2011.Interferon-lambda serum levels in hepatitis-C,J Hepatol 54 859 -65
AkkarathamrongsinS,ThongVD,PoovorawanK,PrapunwattanaP, 2014.IFNL3 (IL-28B) and IFNL-4 polymorphisms are associated with treatment response in Thai patients infected with HCV genotype-1, but not with genotypes-3 and 6,J Med Virol 86 1482 -90
GuptaAC,TrehanpatiN,SukritiS,HissarS,MidhaV,SoodA, 2014.Interleukin-28b CC genotype predicts early treatment response and CT/TT genotype-spredicts non-response in patients infected with HCV genotype-3,J Med Virol 86 707 -12
EslamM,LeungR,Romero-GomezM,MangiaA,IrvingWL,SheridanD, 2014.IFNL-3 polymorphisms predict response to therapy in chronic hepatitis-C genotype 2/3 infection,J Hepatol 61 235 -41
MangiaA,MottolaL,SantoroR, 2013.Interleukin-28B polymorphisms as predictor of response in hepatitis-C virus genotype-2 and 3 infected patients,World J Gastroenterol 19 8924 -8
MoghaddamA,MelumE,ReintonN,Ring-LarsenH,VerbaanH,BjøroK, 2011.-28B genetic variation and treatment response in patients with hepatitis-C virus genotype-3 infection,Hepatology 53 746 -54
MangiaA,ThompsonAJ,SantoroR,PiazzollaV,TillmannHL,PatelK, 2010.An IL-28B polymorphism determines treatment response of hepatitis C virus genotype 2 or 3 patients who do not achieve a rapid virologic response,Gastroenterology 139 821 -7
BrunoS,ThompsonAJ,CritelliR,CrosignaniA,RossiS,De LisiS, 2015.Interferon lambda-3 is not associated with clinical outcome in patients with HCV-induced compensated cirrhosis: A long-term cohort study,Antiviral Res 113 27 -32
SuppiahV,MoldovanM,AhlenstielG,BergT,WeltmanM,AbateML, 2009.IL28B is associated with response to chronic hepatitis-C interferon-alpha and ribavirin therapy,Nature Genetics 41 1100 -4
TanakaY,NishidaN,SugiyamaM,KurosakiM,MatsuuraK,SakamotoN, 2009.Genome-wide association of IL-28B with response to pegylated interferon-alpha and ribavirin therapy for chronic hepatitis-C,Nature Genetics 41 1105 -9
StättermayerAF,StauberR,HoferH,RutterK,BeinhardtS,ScherzerTM, 2011.Impact of IL28B genotype on the early and sustained virologic response in treatment-naïve patients with chronic hepatitis-,Clin Gastroenterol Hepatol 9 344 -50
RauchA,KutalikZ,DescombesP,CaiT,Di IulioJ,MuellerT, 2010.Genetic variation in IL-28B is associated with chronic hepatitis-C and treatment failure: a genome-wide association study,Gastroenterology 138 1338 -45
GélinasJF,FabreT,WillemsP,LeungRC,GeorgeJ,WillemsB, 2013.IL28B SNP screening and distribution in the French Canadian population using a rapid PCR-based test,Immunogenetics 65 397 -403
StättermayerAF,StrasslR,MaieronA,RutterK,StauberR,StrasserM, 2014.Polymorphisms of interferon-λ−4 and IL-28Beffects on treatment response to interferon/ribavirin in patients with chronic hepatitis-C. Aliment Pharmacol Ther, 39 104 -11
SusserS,HerrmannE,LangeC,HamdiN,MüllerT,BergT, 2014.Predictive value of interferon-lambda gene polymorphisms for treatment response in chronic hepatitis-C,PLoS One 9 e112592 -
JiaZ,DingY,TianS,NiuJ,JiangJ, 2012.Test of IL-28B polymorphisms in chronic hepatitis-C patients treated with PegIFN and ribavirin depends on HCV genotypes: results from a metaanalysis,PLoS One 7 e45698 -
0

Citations

0

Downloads

58

Views